Interestingly, Gem+ICB+CCR2i combination treatment also increased the frequency of iNOS+ cells, a marker of classically activated macrophages, in the tumor microenvironment (TME) (Supplemental Figure 6B). Here, NOS2 is linked to neoplasm.